Heart Disease in Women Statistics in US 2026 | Key Facts

Heart Disease in American Women 2026

Heart disease in women remains the most deadly and persistently underestimated health threat facing American women today. Despite growing public health campaigns and decades of research investment, the numbers tell a sobering story that refuses to improve fast enough. According to the latest data from the Centers for Disease Control and Prevention (CDC) and the AHA 2025 Heart Disease and Stroke Statistics Update — published in Circulation on January 27, 2025, and representing the most comprehensive dataset available as of 2026 — 44.8% of US women aged 20 and older are living with some form of cardiovascular disease (CVD). In real numbers, that translates to tens of millions of American women managing a condition that is, right now, the leading cause of their death. In 2022 alone, CVD caused the deaths of 446,912 females in the United States — accounting for 47.5% of all CVD deaths nationwide.

What makes the 2025/2026 heart disease picture for women particularly alarming is not just the raw mortality count, but the stubborn persistence of awareness gaps, treatment disparities, and worsening risk factor profiles. Only about 56% of US women recognize that heart disease is their number one killer. At the same time, new data confirms that non-Hispanic Black women face a cardiovascular disease prevalence of 59.0% — the highest of any female demographic group in the country — while obesity among adult women has reached 41.8% nationally, and 58.4% of non-Hispanic Black women have high blood pressure. These are not slow-moving trends; they are accelerating crises. The data presented throughout this article is drawn exclusively from verified, official US government and major scientific sources — the CDC, NCHS, NHLBI, and the AHA’s annual statistical update — to give the clearest, most current picture of heart disease in women in the US in 2026.

Key Interesting Facts: Heart Disease in Women in the US 2026

Data Source: AHA 2025 Heart Disease and Stroke Statistics Update — Females & CVD Fact Sheet; Martin SS et al., Circulation, published online January 27, 2025. CDC Heart Disease Facts, updated October 2024; NCHS Multiple Cause of Death 2018–2023, CDC WONDER Database, accessed February 1, 2025.

The weight of these numbers is almost impossible to fully absorb, but it is essential that women, their healthcare providers, and policymakers do exactly that. 446,912 female lives were claimed by cardiovascular disease in a single year — 2022 — meaning that heart disease killed nearly 1,224 women every single day in the United States. And yet fewer than 6 in 10 women know that heart disease is their leading cause of death. That gap between reality and perception is not just a communications failure — it is a factor that directly contributes to delayed diagnoses, under-treatment, and avoidable death. The average age of first heart attack in women is 72.0 years, more than six years later than men, which has historically caused women’s cardiac risk to be minimized. But older age at first event does not mean lower risk — it means women are less likely to survive and more likely to experience worse outcomes.

The racial data embedded in this table deserves separate, urgent attention. When 59.0% of non-Hispanic Black women are living with some form of cardiovascular disease, and 58.4% of that same group has high blood pressure — the single greatest modifiable risk factor for heart disease and stroke — this is a public health emergency layered on top of a public health emergency. The disparity is not explained away by biology alone; it is the measurable result of structural racism, unequal access to healthcare, food insecurity, and chronic stress acting on the cardiovascular system over decades. Meanwhile, obesity has reached 57.9% among non-Hispanic Black adult women and 41.8% among all adult women, feeding a pipeline of diabetes, hypertension, and ultimately heart disease that the current healthcare system is not adequately equipped to intercept.

Overall Prevalence of Heart Disease in Women in the US 2026

Data Source: AHA 2025 Heart Disease and Stroke Statistics Update — Females & CVD Fact Sheet and At-a-Glance Fact Sheet; Martin SS et al., Circulation, January 27, 2025. CDC Heart Disease Facts, October 2024.

The overall picture of heart disease prevalence among women in the US in 2025/2026 is one of entrenched, massive scale. With 44.8% of women aged 20 and older carrying some form of cardiovascular disease, this is not a niche or aging-population issue — it is the dominant health condition affecting nearly half of all adult women in America. The 941,652 total CVD deaths in 2022 confirmed that cardiovascular disease remained the number one killer of Americans that year, ahead of all cancers and accidental deaths combined. Females accounted for 47.5% of those deaths, with 446,912 women losing their lives to CVD in 2022 alone. Within that total, coronary heart disease was the leading cause of CVD death — and it claimed 147,554 female lives, along with 41,334 women who died specifically from myocardial infarction in 2022.

The data on women who survive a first heart attack is equally alarming and rarely discussed publicly. Based on clinical outcome data, 23% of women aged 45 and older who had an initial recognized MI died within one year — compared to 18% of men. Within five years after a first MI, the gap widens further: 47% of women died, versus 36% of men. Women have heart attacks at older ages than men and are demonstrably more likely to die from them within weeks of the event. The average age of first MI for women is 72.0 years (vs. 65.6 for men) — and at that age, women are more likely to have comorbidities, more likely to present with atypical symptoms, and more likely to receive delayed or less aggressive treatment. Approximately 1 in 5 heart attacks are silent, meaning damage occurs without recognition — a pattern disproportionately experienced by women, whose symptoms are frequently atypical and misdiagnosed.

Heart Disease in Women by Race and Ethnicity in the US 2026

Data Source: AHA 2025 Heart Disease and Stroke Statistics Update — Females & CVD Fact Sheet; Martin SS et al., Circulation, January 27, 2025. TCTMD and AHA press release summary of 2025 data; NHLBI NHANES tabulations, 2017–2020.

The racial and ethnic disparities in heart disease among women in the US represent one of the most persistent and consequential failures in American public health. The AHA 2025 Females & CVD Fact Sheet makes the data plain: 59.0% of non-Hispanic Black women aged 20 and older are living with some form of cardiovascular disease — a rate that dwarfs the national female average of 44.8% and exceeds that of every other female demographic group. This is not a marginal difference. It represents a community where the majority of adult women are managing a serious, life-limiting cardiovascular condition. Non-Hispanic Black women also carry the highest rates of high blood pressure (58.4%), heart failure (3.3%), and prior stroke (5.4%) among all female racial groups — each of these conditions compounding and accelerating the others. At the same time, the age-adjusted CVD death rate for all women stands at 183.1 per 100,000 — but that aggregate conceals the full extent of racial inequity beneath it.

The contrast across groups is stark and instructive. Non-Hispanic Asian females have the lowest age-adjusted CVD death rate of any group at 104.9 per 100,000, while Hispanic women show the lowest high blood pressure rate among female groups at 35.3% — and the lowest overall CVD prevalence at 37.3%. However, for Hispanic women, lower prevalence numbers can partly reflect healthcare access disparities, younger population demographics, and underdiagnosis rather than lower true burden. The CHD prevalence across racial groups shows less dramatic spread than overall CVD: 5.9% for NH White, 6.3% for NH Black, 6.1% for Hispanic, and 3.9% for NH Asian women — suggesting that while coronary artery disease is common across all groups, the downstream complications cluster most severely in Black women. Addressing racial disparities in heart disease among women in the US in 2026 requires confronting the structural determinants — income inequality, food access, healthcare affordability, housing stress — that make these numbers possible and perpetuate them year after year.

High Blood Pressure as a Risk Factor for Heart Disease in Women in the US 2026

Data Source: AHA 2025 Heart Disease and Stroke Statistics Update — Females & CVD Fact Sheet and At-a-Glance Fact Sheet; Martin SS et al., Circulation, January 27, 2025. CDC — About Women and Heart Disease, updated May 2024.

High blood pressure is the single most dangerous and modifiable risk factor for heart disease and stroke in women, and the 2025 data makes it clear that the US is failing to manage it adequately. 59.6 million women — 43% of all adult women in the United States — have hypertension, and the control rates are dismal across every racial group. Even among non-Hispanic White women, who have the highest control rates, only 27.6% have their blood pressure adequately managed. For non-Hispanic Black women, that figure drops to 25.6%, and for Mexican American women, it falls to just 23.9%. In practical terms, the overwhelming majority of women with high blood pressure in the United States are walking around with a major, active cardiovascular risk factor that is not under control. High blood pressure has no symptoms — it silently damages the heart, arteries, kidneys, and brain — and then one day, announces itself through a heart attack or stroke. In 2022, high blood pressure was responsible for 67,553 female deaths — more than 51% of all HBP deaths in the entire country.

The pregnancy dimension of high blood pressure adds yet another urgent layer to this story. High blood pressure develops in 1 in every 8 US pregnancies (13.0%), and women who experience hypertension during pregnancy carry twice the risk of developing heart disease later in life compared to those with uncomplicated pregnancies. This means that for a significant share of American women, the trajectory toward heart disease can be set as early as their first pregnancy — often in their 20s or early 30s — and yet most postpartum cardiovascular risk assessment and follow-up is cursory at best. The data tells the same story from every angle: high blood pressure in women is undertreated, underprioritized, and uniquely dangerous, and it is the single greatest lever available to reduce female heart disease mortality in the US in 2026.

Heart Failure and Stroke in Women in the US 2026

Data Source: AHA 2025 Heart Disease and Stroke Statistics Update — Females & CVD Fact Sheet and At-a-Glance Fact Sheet; Martin SS et al., Circulation, January 27, 2025. CDC Heart Disease Facts, October 2024.

Two of the most consequential and under-discussed aspects of heart disease in women in the US are heart failure and stroke, both of which disproportionately affect women in terms of both prevalence and death. On heart failure: 3.0 million adult women currently live with this condition, which occurs when the heart is too weak to pump enough blood to support the body’s organs. The racial disparity is glaring — non-Hispanic Black women have a heart failure prevalence of 3.3%, exactly double the rate seen in non-Hispanic White and Hispanic women. And in 2022, women accounted for 52.6% of all heart failure deaths — meaning heart failure kills more women than men in absolute terms, despite men carrying a higher overall prevalence. This is partly because heart failure strikes women at older ages and with different underlying pathophysiology, often involving preserved ejection fraction, which is harder to treat and carries worse outcomes than the form more commonly seen in men.

The stroke data is equally striking and reinforces the case that cardiovascular disease in women requires a far more comprehensive approach than coronary artery disease screening alone. As of 2017–2020 data, 5.4 million women had experienced a prior stroke — more than the 4.0 million men with the same history. Women account for 56.6% of all stroke deaths in the US, and the age-adjusted stroke death rate increased 7.0% from 2012 to 2022, reaching 39.5 per 100,000 — a trend moving in exactly the wrong direction. Non-Hispanic Black women bear the heaviest stroke burden among female groups, with a 5.4% prior stroke prevalence — more than triple the rate seen in non-Hispanic Asian women at 1.5%. These numbers are the direct downstream consequence of the hypertension, diabetes, obesity, and atrial fibrillation disparities concentrated in the Black female population. Stroke and heart failure among women in the US in 2026 are not separate crises from heart disease — they are its most severe and measurable consequences.

Economic and Financial Burden of Heart Disease in Women in the US 2026

Data Source: AHA 2025 Heart Disease and Stroke Statistics Update — At-a-Glance Fact Sheet and Older Americans Fact Sheet; Martin SS et al., Circulation, January 27, 2025. NHLBI unpublished tabulations using MEPS Household Component, average annual 2019–2020.

The financial burden of heart disease in the United States has reached a scale that demands urgent policy action, and women are central to this economic equation. According to the AHA 2025 Statistics Update, the total direct and indirect costs of cardiovascular disease in the US for 2020–2021 reached $417.9 billion — with $233.3 billion in direct healthcare costs and $184.6 billion in indirect costs from lost productivity, disability, and premature mortality. Direct CVD costs have surged from $189.7 billion in 2012–2013 to $233.3 billion in 2020–2021, a trajectory that — if current risk factor trends continue — is projected to produce a 300% increase in CVD-related healthcare costs by 2050. For patients aged 65 and older, who represent the majority of women experiencing heart disease at its most serious stages, CVD and stroke costs totaled $174.4 billion — roughly 42% of all CVD and stroke expenditures in the US. CHD alone carries an estimated annual direct and indirect economic burden of $129.3 billion.

For women, the economic impact reaches far beyond hospital bills. Women who survive heart attacks are more likely to face longer recovery periods, higher readmission rates, and greater long-term functional decline than men — all of which translate into reduced workforce participation, higher out-of-pocket healthcare costs, and greater reliance on caregiving support. Many of the women most affected by cardiovascular disease — older, lower-income, and from communities of color — are also among those with the least financial cushion to absorb these costs. The grim financial outlook reinforces a critical point: investing in prevention, early detection, and equitable cardiovascular care for women is not just a moral imperative — it is an economic necessity. The alternative — a 300% projected cost increase by 2050 — is neither sustainable for healthcare systems nor acceptable for a country with the resources to do far better.

Lifestyle, Obesity, and Diabetes Risk Factors for Heart Disease in Women in the US 2026

Data Source: AHA 2025 Heart Disease and Stroke Statistics Update — Females & CVD Fact Sheet and At-a-Glance Fact Sheet; Martin SS et al., Circulation, January 27, 2025. CDC Heart Disease Facts, October 2024.

The lifestyle and metabolic risk factor data for women and heart disease in the US in 2025/2026 paints a picture of multiple crises converging simultaneously. 41.8% of all adult US women have obesity — a figure that rises to a staggering 57.9% among non-Hispanic Black women and 45.7% among Hispanic women. Obesity is not merely a cosmetic concern; it is a direct upstream driver of hypertension, type 2 diabetes, high cholesterol, and cardiovascular disease. The data on diabetes is equally alarming: 12.9 million women have diagnosed diabetes, representing 9.1% of all adult women, and an additional 5.1 million women have diabetes they are unaware of. Even more striking, 52.4 million women — 40% of all adult females — have prediabetes, meaning they are already on a physiological trajectory toward full diabetes and the associated heightened cardiovascular risk. In 2022, diabetes caused 43,652 female deaths in the US, and CVD remains the leading cause of death among people with diabetes overall.

Physical inactivity is another compounding driver of this crisis that affects women at higher rates than men. Among female adults, only 28.7% of women aged 18–34 and a mere 10.8% of women aged 65 and older meet both the aerobic and muscle-strengthening physical activity guidelines — and the gap widens with age, precisely when cardiovascular risk is rising most steeply. Among high school girls, only 15.7% are physically active for 60 minutes or more on all 7 days of the week, compared to 31.7% of male students — establishing unhealthy patterns early that will carry forward into adulthood. On smoking, 10.1% of adult women are current cigarette users — and women who smoke face disproportionately higher cardiovascular risk compared to male smokers at comparable use levels. These risk factors do not operate in isolation; they stack, compound, and accelerate one another, creating a cardiovascular risk burden for women in the US in 2026 that is both entirely measurable and disturbingly preventable.

Cardiovascular Disease Projections for Women in the US 2026

Data Source: AHA 2025 Heart Disease and Stroke Statistics Update — At-a-Glance Fact Sheet; Martin SS et al., Circulation, January 27, 2025. HCPLive and AHA press release summaries of AHA 2025 update projections. AHA Scientific Statement, Circulation, February 25, 2026.

The forward-looking data on cardiovascular disease among women in the US is as alarming as the current numbers, if not more so. While the age-adjusted CVD death rate fell slightly from 233.3 per 100,000 in 2021 to 224.3 per 100,000 in 2022 — a modest positive signal following the COVID-19 pandemic spike — the underlying risk factor trends are moving sharply in the wrong direction. The AHA 2025 Statistics Update projects that if current trends continue unabated, hypertension and obesity will each affect more than 180 million US adults by 2050, and diabetes will climb to over 80 million. This will drive a 300% increase in CVD-related healthcare costs over the same period — a projection that, if realized, would be catastrophic for both the healthcare system and individual families. The newest AHA scientific statement, published in Circulation on February 25, 2026, confirmed that 6 out of 10 women in the United States are projected to develop at least one form of cardiovascular disease in the coming decades — the direct consequence of these worsening risk factor trajectories.

The broader global context reinforces that this is not a problem unique to the US — but the US has both the resources and the responsibility to do better. Cardiovascular disease caused 19.41 million global deaths in 2021, with high systolic blood pressure alone responsible for 10.85 million of those deaths. In the United States, the fact that approximately 1 in 6 CVD deaths now occurs in adults under the age of 65 — premature cardiovascular mortality — signals that this disease is not simply following older Americans to the end of their natural lifespan. It is cutting short the lives of working-age women and men, mothers and fathers, with decades ahead of them. Every year of delayed action on obesity, hypertension, physical inactivity, and diabetes translates into hundreds of thousands more preventable heart disease deaths among women in the US. The projections for 2026 and beyond are not destiny — but they are a warning that demands immediate, structural, and equitable response.

Disclaimer: The data reports published on The Global Files are sourced from publicly available materials considered reliable. While efforts are made to ensure accuracy, no guarantees are provided regarding completeness or reliability. The Global Files is not liable for any errors, omissions, or damages resulting from the use of these reports.